Immunocompetent Versus Immunocompromised Tuberculosis (TB) Patients
Launched by SOHAG UNIVERSITY · Nov 27, 2024
Trial Information
Current as of August 29, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating tuberculosis (TB) in two groups of patients: those with healthy immune systems (immunocompetent) and those with weakened immune systems (immunocompromised). TB is a serious disease caused by bacteria that can spread through the air and is a leading cause of death worldwide, especially among people living with HIV. The goal of this trial is to better understand how TB affects these different groups of patients, which could help improve treatment and prevention strategies.
To participate in this trial, individuals must be between the ages of 58 and 219 years and have a chronic chest disease. However, people with other respiratory or infectious diseases will not be eligible. While the trial is not yet recruiting participants, those who join can expect to contribute to important research that may help improve outcomes for TB patients in the future. This study is crucial because it aims to gather more information about how TB impacts people with varying immune health, which could lead to better care for everyone affected by this disease.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with chronic chest disease
- Exclusion Criteria:
- • Patients with other respiratory or infectious diseases.
About Sohag University
Sohag University is a distinguished academic institution located in Sohag, Egypt, committed to advancing healthcare through rigorous clinical research. As a clinical trial sponsor, the university leverages its robust infrastructure and multidisciplinary expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a focus on ethical standards and scientific integrity, Sohag University collaborates with healthcare professionals and researchers to conduct trials that address critical health issues, ensuring the advancement of evidence-based practices in the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sohag, , Egypt
Patients applied
Trial Officials
Noha S Shafik, Lecturer
Principal Investigator
Sohag university, Faculty of medicine
Asmaa T Mostafa, Lecturer
Study Chair
Sohag university, Faculty of Medicine
Ebtisam M Gad, Lecturer
Study Chair
Sohag university, Faculty of Medicine
Mona M Abdelrahman, Lecturer
Study Chair
Sohag university, Faculty of Medicine
Dina H Mohamed, Lecturer
Study Chair
Sohag university, Faculty of medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported